Published research, including studies referenced in NIH literature, shows associations between berberine and glucose management support, GLP-1 pathway activity in animal and some human models, and reductions in fasting glucose readings in controlled research settings
Development and application of monoclonal antibodies against the mycotoxin mycophenolic acid
Retatrutide's phase 2 obesity trial found gastrointestinal adverse events were most common during dose escalation and were usually mild to moderate
Many users find success switching to caffeine-free herbal teas, decaffeinated options, or limiting caffeine to a single small cup consumed with food
The main issue with weight gain and modern health, especially in countries like the United States, is the widespread consumption of highly processed foods and sedentary lifestyle
Drinking heavily on dose day